1. Introduction {#sec1}
===============

Epigenetics is receiving more and more attention in molecular biology fields. Diet nutrient changes can alter gene expression without changing the DNA sequence and affect the development of embryo, the growth and health of animals by epigenetics mechanisms ([@bib18], [@bib23]). By exploiting the relationship between nutrition and gene expression, the epigenetic phenomena related to growth and health processes can be regulated ([@bib4], [@bib7], [@bib28], [@bib68]). This dynamic relationship between nutrition and gene expression throughout the lifetime of an organism has now been recognized as a subfield called 'nutritional epigenomics' and provides a promising insight into the targeting growth and health of animals from a nutritional standpoint ([@bib4], [@bib43]).

Epigenetic processes include the modification of DNA by cytosine-guanine (CpG) sites methylation ([@bib26], [@bib29], [@bib57]), which is one form of epigenetic modification widely studied ([@bib3], [@bib12], [@bib17], [@bib40]). Methionine, an essential amino acid, serves as the precursor of S-adenosylmethionine (SAM) in the one-carbon metabolism ([@bib36]). Recent studies demonstrate its essential role in diverse cellular processes ([@bib10], [@bib45], [@bib69]) and the liver is the site where nearly half of the methionine metabolism and 85% of all methylation reactions takes place ([@bib33]). The fluctuation of methionine can influence DNA methylation and consequently contribute to the dysregulation of gene expression, finally cause the pathogenesis and progression of liver disease ([@bib35]). However, reviews focused on the relationship between methionine and epigenetics are fairly poor in the past decades, except that by [@bib64] who reviewed the effects of high methionine intake on DNA methylation. In this paper, we will focus on the effects of dietary methionine fluctuation on one-carbon metabolic substrates and the critical epigenetic role of DNA methylation in alteration of gene expression in animals.

2. Nutritional epigenomics {#sec2}
==========================

Nutrients can affect gene expression via epigenetic mechanisms ([@bib68]). Epigenetics is the phenomenon related to mitotically heritable yet potentially reversible DNA modifications but with no change of the DNA sequence ([@bib57]), providing a connection between environment (e.g., nutritional factors) and health of animals and humans. Epigenetics builds a firm link between phenotypic plasticity and fixed genotype, and plays an important role for creating and keeping the diversity of gene expression patterns in animals. Epigenetic modifications consist of DNA methylation, histone modification, microRNA and non-coding RNA regulation ([@bib58]). DNA methylation is widespread in animals and suppresses gene transcription by directly or indirectly methylating the CpG islands in gene promoters, playing critical roles in epigenetic processes ([@bib26]). DNA methyltransferases (DNMT) are key enzymes for activating DNA methylation in animals ([@bib37]). Three active DNMT (DNMT1, DNMT3a, and DNMT3b) are responsible for *de novo* methylation ([@bib5]). DNA methyltransferase 1 prefers for hemimethylated DNA and keeps the methylation pattern intact after DNA replication ([@bib27], [@bib30]) while DNMT3a and DNMT3b do not distinguish between methylated substrates ([@bib30]). Furthermore, DNA methylation occurs dramatically in the early development stage of mammals ([@bib50]). More interestingly, the methylation in the body of genes can actually activate gene transcription compared with methylation in promoters ([@bib31]). The genome is constant, but the gene regulation effects of DNA methylation may vary across positions of methylation in genes, tissues, and development stages ([@bib25]). Nutrients may have a critical role in affecting epigenetic modifications, providing possible ways through which nutrients may regulate gene expression and final phenotypes in animals ([@bib46]).

Methionine is vital in epigenetic reactions by donating methyl groups to methylating cytosine in CpG islands ([@bib54]). Actually, it is the DNMT that converts SAM to S-adenosylhomocysteine (SAH) ([@bib54]). Importantly, the SAM is generated from methionine through the adenylation of methionine catalyzed by methionine adenosyltransferase (MAT) ([@bib20]). Generally, SAH is hydrolyzed by adenosylhomocysteinase (Ahcy) into homocysteine (Hcy) and adenosine as long as the latter is removed through other metabolic pathways. If not, the reverse reaction will occur to increase the concentration of SAH ([@bib44]). The thermodynamics of Ahcy favors SAH biosynthesis rather than hydrolysis ([@bib20]) except Hcy is rapidly removed, which is essential to preventing the accumulation of SAH ([@bib33]). There exit 2 outlets for Hcy: one is regeneration of methionine by betaine--homocysteine methyltransferase (BHMT) or 5-methyltetrahydrofolate--homocysteine methyltransferase (MS), another way is entering the transsulfuration pathway and to generate cystathionine by cystathionine β-synthase ([@bib33]).

Nutritional factors, e.g., methionine, influencing the metabolism of SAM and SAH, may have impact on DNA methylation. The establishment of epigenome is vulnerable to nutritional factors especially during the prenatal and early postnatal stages of animals ([@bib36], [@bib68]). Therefore, nutritional challenges during the early development stage might have a dramatic impact on the DNA methylation, the growth and health of animals ([@bib68]). Besides, epigenetic variations may happen in the "dietary transition" period, in which animals are exposed to a nutritionally imbalanced diet that may affect the DNA methylation ([@bib68]). There are many studies that have reported the effects of nutritional supplementation, e.g., dietary methionine deficiency or excess, during pre- and post-natal stages on the global or locus specific alterations in DNA methylation, and the long-term impacts on the gene expression and consequently growth and health of animals ([@bib14], [@bib45], [@bib65]).

3. Methionine and one-carbon metabolic substrates {#sec3}
=================================================

Previous studies have indicated a firm connection between dietary and hepatic methionine levels ([@bib40]). Feeding very high levels of dietary methionine (1.5%) in weanling rats for 2 weeks resulted in a 4- to 30-fold accumulation of methionine in the intestine, liver, skeletal muscle, kidney and plasma compared with feeding a diet containing 0.61% methionine ([@bib42]). Similarly, methionine injection (100 mg/kg) in adult epileptic rats caused a 7-fold increase in methionine of hippocampus compared to control rats ([@bib40]). However, the effect of dietary methionine intakes on the hepatic methionine is not always in distinct proportions. No change in hepatic methionine was observed in adult rates fed purified diets with different methionine contents (0.3%, 1%, 1.5%, 2%, or 3% methionine; wt/wt) lasting for 7 days, showing effectual metabolic equilibrium facing dietary methionine excess ([@bib21]). More interestingly, [@bib1] found that hepatic methionine levels substantially decreased in mice fed either a methionine-deficient or methionine-supplemented diet. A decrease in hepatic methionine level in mice fed a methionine deficient diet was expected, but not in those fed the methionine-supplemented diet.

Generally, an increase in hepatic SAM is expected when dietary methionine intake is increased ([@bib48]). Consequently, SAM would be converted to SAH by DNMT. But the activity of DNMT can be inhibited by a high intracellular SAH concentration ([@bib48], [@bib47]). The results of previous research have illustrated a tight association between dietary methionine intake and one-carbon metabolic substrates, e.g., SAM and SAH, in liver or other organs ([Table 1](#tbl1){ref-type="table"}). Hepatic SAM level was maintained, whereas SAH gradually increased with the increase of dietary methionine from 0.3% to 2.0% in the study of [@bib21], illustrating a tremendous reduction in the ratio of SAM to SAH. Similarly, brain SAH was doubled with the injection of methionine (2 g/kg per day) subcutaneously lasting for 15 days in male mice, whereas SAM was not affected, and the ratio of SAM to SAH was decreased ([@bib56]). In another study, providing 0.5% methionine in the drinking water from 7 to 15 weeks, the hepatic and cerebral SAH in weanling mice increased, whereas SAM was not affected. Furthermore, the ratio of SAM to SAH decreased ([@bib15]). These results suggest that the elevated SAH should inhibit the SAM-dependent methyltransferase reactions ([@bib59]), including Glycine N-methyltransferase (GNMT) which functions to regulate SAM levels and the ratio of SAM to SAH ([@bib47]), and reduce the hepatic and cerebral capacity of methylation ([@bib6], [@bib9], [@bib11], [@bib13]). However, the hepatic SAM increased 10 and 20 times, while SAH increased 30% and 4 times in rats fed diets containing 1.3% and 2.3% methionine, respectively, compared with control rats pair-fed a diet containing 0.3% methionine ([@bib48]). Consequently, the hepatic ratio of SAM to SAH increased 8 times in both 1.3% and 2.3% methionine diets, respectively, compared with control diet ([@bib48]). Similarly, an 80% increase of the hepatic ratio of SAM to SAH was observed following the 7 times of SAM and 4 times of SAH increases caused by a 1.5% dietary methionine intake ([@bib42]). The 1.7% methionine diet increased the serum SAM, SAH and ratio of SAM to SAH, especially the serum SAH concentration, which was elevated by 2.28 folds ([@bib67]). Furthermore, the SAM, SAH concentration increased in oocytes of rainbow trout which were fed 2% methionine diets for 6 months, but the ratio of SAM to SAH was decreased ([@bib22]). More interestingly, hepatic SAM and SAH levels were both increased in mice fed diets supplemented 0 or 2% methionine but the ratio of SAM to SAH seemed unaffected ([@bib1]). Similarly, both renal SAM and SAH levels increased but only SAH showed a significant difference, while the SAM to SAH ratio remained unchanged in rats fed both the methionine-supplemented (2% methionine) and methionine-deficient (0.3% methionine) diets ([@bib2]).Table 1Summary of relevant studies showing effects of methionine on one-carbon metabolic substrates in humans and model organisms.Table 1Methionine condition, %SpeciesPeriod of dietary inputLastedTissueOne-carbon metabolites modification(s)ReferencesDiets, 0.3, 1.0, 1.5, 2.0, 3.0Rat250 g weight7 dLiverSAM -, SAH ↑, SAM:SAH ↓[@bib21]Injection, 6.6 mmol/kg subcutaneouslyMice60 d of age15 dBrainSAM -, SAH ↑, SAM:SAH ↓[@bib56]Drinking, 0, 0.5MiceWeanlingFrom 7 to 15 wk,Liver and brainSAM -, SAH ↑, SAM:SAH ↓[@bib15]Diets, 0.61, 1.5RatWeanling2 wkLiverSAM ↑, SAH ↑, SAM:SAH ↑[@bib42]Diets, 0.3, 1.3, 2.3Rat54 to 74 g weight10 dLiverSAM ↑, SAH ↑, SAM:SAH ↑[@bib48]Diets, 0, 1.7Mice6 wk of age20 wkSerumSAM ↑, SAH ↑, SAM:SAH ↑[@bib67]Diets, 0.5, 1, 2Rainbow troutBrood stock6 monthsOocytesSAM ↑, SAH ↑, SAM:SAH ↓[@bib22]Diets, 0.3, 2Rat5 to 6 wk of age6 wkKidneySAM -, SAH ↑, SAM:SAH -[@bib2]Diets, 0, 2Mice4 wk of age10 wkLiverSAM ↑, SAH ↑, SAM:SAH -[@bib1][^1]

Enzyme-catalyzed reaction is determined by substrate supply and production removal. Therefore, the ratio of SAM to SAH was called 'methylation index' in the context of methylation reaction, including hypo-methylation and hyper-methylation. However, methylation reaction is much more complex as besides the substrates (SAM) and production (SAH), and there are other factors affecting the transmethylation efficiency, e.g., animal age, breed and diet. Furthermore, there is more and more evidence that methylation reaction is tissue specific ([@bib24], [@bib61]). Relevant studies showing the effects of methionine on one-carbon metabolic substrates in humans and animals are summarized in [Table 1](#tbl1){ref-type="table"}, suggesting different methylation patterns that occur in different tissues with dietary methionine supplementation. More importantly, recent genome wide methylation analysis revealed that DNA hyper-methylation does not always repress gene expression ([@bib68]).

4. Methionine and DNA methylation {#sec4}
=================================

Theoretically, supplementation of methionine would increase the DNA methylation of genes and down-regulate gene expression ([@bib64]). Indeed, hypermethylation in the reelin promoter and down-regulated reelin gene expression were observed in cortex of mice by methionine supplementation (6.6 mmol/kg) ([@bib56]). Reelin is a secreted extracellular matrix protein that is reduced in brains of patients with schizophrenia ([@bib56]). Consistent with the hypermethylation in specific CpG sites, the 15-d methionine treatment facilitated the connection of methyl CpG binding protein 2 (MeCP2) and the reelin promoter ([@bib16]). However, it does not happen on control genes, e.g., glutamic acid decarboxylase 65 (*GAD65)* and β-globin.

Brain derived neurotrophic factor (*Bdnf*), which presents in the central nervous system, is one member of the memory-permissive genes. Methionine administration significantly caused hyper-methylation of *Bdnf* DNA and, consequently, repressed gene expression of *Bdnf* mRNA in the epileptic hippocampus. Interestingly, the most significant DNA methylation of *Bdnf* occurred at CpG sites 5, 8, and 12, showing the importance of these sites in *Bdnf* transcription ([@bib40]).

As one of the key enzymes of transmethylation reaction from SAM to SAH in one-carbon metabolism, GNMT is present in large amounts in the liver, and in smaller amounts in other tissues such as kidney and intestinal mucosa ([@bib33]), and is vital in avoiding drastic fluctuations of intracellular SAM concentrations to prevent aberrant methylation reactions ([@bib33]). As an index of liver methylation capacity, the hepatic SAM to SAH ratio is increased 100-fold, resulted from a 40-fold increment of SAM and a 4-fold reduction of SAH in GNMT knock-off mice ([@bib34]). Consequently, there is global DNA hypermethylation ([@bib34]).

Protein phosphatase 2A (PP2A) is a conserved protein phosphatase that regulates growth processes by dephosphorylating specific target proteins, including the target of rapamycin complex 1 (TORC1) ([@bib32], [@bib52]). S-adenosylmethionine- and methionine-treated hepatocytes showed increased PP2A methylation that influences TORC1 activity through modulating the phosphorylation state of Npr2p, which is a negative regulator of TORC1 ([@bib49]). Excess methionine caused high SAM and PP2A hypermethylation in hepatocytes of GNMT-knockout mice, resulting in lipid accumulation ([@bib69]). Normalization of methionine and SAM levels using a methionine deficient diet normalized the methylation capacity, PP2A methylation, and ameliorated liver steatosis ([@bib69]).

In practice, however, the effect of a methionine-supplemented diet on the DNA methylation is not always as expected. Methylenetetrahydrofolate reductase (Mthfr) has an important function for the re-methylation of homocysteine to methionine in the methionine cycle ([@bib20]). Surprisingly, a difference of genome wide DNA methylation was not observed in Mthfr-knockout mice feeding a methionine-supplemented diet, although a huge alteration happened in hepatic ratio of SAM to SAH ([@bib15]). It should be noted that this result does not diminish the role of DNA methylation existing only at specific loci. Theoretically, high dietary methionine levels could change the DNA methylation pattern. However, methionine supplementation (2% methionine) enhanced the renal SAH concentration, but the ratio of SAM to SAH was not affected. At the same time, no significant difference was found in the *p53* gene promoter methylation pattern ([@bib2]).

Fatty acid binding proteins (FABP) can reversibly bind ligands of hydrophobicity, e.g., long-chain fatty acids and other high affinity lipids, and be involved in metabolic pathways in almost all tissues ([@bib55]). The FABP4 is expressed in adipose tissues and is important to the lipid metabolism ([@bib39]). Recently, in an experiment determining the relationship between transmethylation reaction and dietary methionine, significant FABP4 promoter hypo-methylation was observed in ApoE^−/−^ mice with supplementary feeding 1.7% methionine for 20 weeks. The methylation levels of FABP4 promoter region were 47% lower than the control group. Conversely, up-regulation of *FABP4* gene and protein expression was observed, consisting with the DNA methylation pattern ([@bib67]). In the same study, a high level of dietary methionine enhanced the serum SAH and Hcy levels which inhibited *DNMT1* mRNA. The *DNMT1* mRNA expression decreased 52% in the methionine group compared with that in the control group. At the same time, the DNMT1 protein expression parallel altered with the mRNA expression. Conclusively, accumulation of SAH, decreased *DNMT1* gene, and protein expression caused by enhanced Hcy level might have an important impact on the FABP4 promoter demethylation.

Although the importance of DNA methylation in the context of epigenetics has been explored ([@bib7], [@bib51]), the mechanisms governing global and region-specific DNA methylation are poorly understood, specifically in the context of nutri-epigenomics. Methionine as a dietary methyl donor is the major driver of DNA methylation because it is essential for the synthesis of SAM. The expression of specific genes (e.g., *PPARA*) might be silenced or repressed depending on global DNA-hyper or DNA-hypomethylation ([@bib62], [@bib63]). For instance, mice fed a betaine-enriched diet had hypermethylation of hepatic DNA while the *PPARA* promoter region was hypomethylated, consequently up-regulating the expression of *PPARA* ([@bib62]). But Holstein cows fed a methionine-supplemented diet had a lower global DNA methylation and hypermethylation of a *PPARA* specific-DNA region in the promoter ([@bib38]). The DNA sequence variations within specific regions, species, the onset of lactation of cows, and the down-regulation in expression of *DNMT1* possibly are partly responsible for the different outcomes in both global- and region-specific DNA methylation in response to dietary methyl donors. Alterations of methylation condition in a specific CpG site, rather than the whole promoter region, might be enough to change the gene expression ([@bib19]).

5. Methionine and gene expression {#sec5}
=================================

High-methionine diets contribute to the enhancement of target of rapamycin (*TOR*) and insulin-like growth factor-I (*IGF-I*) gene expression, reduction of eukaryotic initiation factor 4E binding protein 1 (*eIF4EBP1*), forkhead box O4 (*FOXO4*) and atrogin-1 gene expression in chicks. Correspondingly, the growth performance, breast muscle production and serum IGF-1 content were increased with high methionine diet in young chicks ([@bib66]). Furthermore, the expression of *IGF-I* and *GHR* was promoted, while that of atrogin-1 and cathepsin L2 (*CTSL2*) was inhibited with supplementation of methionine in the diet of acutely heat stressed broilers ([@bib14]), demonstrating that methionine promoted protein deposition characterized by increased gene expression for protein synthesis and decreased gene expression for protein breakdown. Similarly, the dietary methionine supplementation increased hepatic gene expression in somatotropic axis, e.g., *GHR-I* and *IGF-I*, and decreased gene expression in protein turnover, including the *TOR*, proteasome 20 delta (*Prot 20D*), calpains (*Capn*) 1 and 2, and calpastatin (*Cast*) long and short isoforms. Consequently, the growth performance of juvenile rainbow trout was increased ([@bib45]).

Aberrant methionine cycle may provoke molecular changes of one-carbon metabolism that results in deregulation of cellular hemostasis and health problems. Indeed, methionine deficient diets resulted in liver injury ([@bib8]). The alterations of gene expression included in the methionine cycle network should be the indicators to determine the mechanisms of abnormal dietary methionine supply on the aberrant development and health of animals. Specifically, the expression of SAH hydrolase (*Ahcy*) and cystathionine-synthase (*Cbs*), which are 2 key genes in hepatic one-carbon metabolism, was decreased in mice fed a methionine-deficient diet ([@bib1]), suggesting an aberrant gene expression profile of hepatic one-carbon. This suggests that a tight connection exists between the elevated hepatic SAH and homocysteine contents and the methionine-deficient diet. As the only enzyme controlling the reversible catabolism of SAH to homocysteine, *Ahcy* is encoded by the *Ahcy* gene in mammals ([@bib54]). Cystathionine beta-synthase is encoded by the *Cbs* gene and responsible for the transsulfuration pathway, which controls the removal of homocysteine ([@bib53]).

There is growing evidence that the lipid metabolic pathway is affected by methionine ([@bib41], [@bib60]). Therefore, the expression of key genes in lipid metabolism requires attention. Indeed, dietary methionine deficiency or excess up-regulated lipogenic transcription factors, mainly *SREBP1* and *CEBPα*, is usually followed by enhanced expression of fatty acid synthase gene *(Fasn)*, and inhibited lipid catabolism gene expression including *Adipor2*, *Cpt1*a, and *Chrebp* genes ([@bib1]). Either methionine deficiency or excess inhibited hepatic lipid catabolism and contributed to lipid accumulation in the liver of mice, but it was substantially greater in the liver of mice fed a methionine-deficient diet. Furthermore, methionine deficiency enhanced lipid turnover efficiency characterized by a substantially increase in gene expression of glucose transporter type 4 (*GLUT4*), malic enzyme 1 (*ME1*), *FASN*, hormone sensitive lipase (*HSL*) gene, and adipose triglyceride lipase (*ATGL*) in subcutaneous and perirenal adipose tissues in pigs ([@bib10]). Recently, an up-regulation of the expression of *PPARA* and its target genes, including *ANGPTL4*, *FGF21*, and *PCK1*, were observed with methionine supplementation in peripartal dairy cattle ([@bib38]), indicating that supplemental methionine activated *PPARA*-regulated signaling pathways, improved lipid metabolism and immune function.

6. Conclusions {#sec6}
==============

Either methionine deficiency or excess in diets can have massive impacts on hepatic methionine cycle, which may result in marked alterations of metabolic substrates, e.g., SAM, SAH, and homocysteine. Therefore, a change in the dietary methionine level could easily alter the status of CpG methylation, gene expression related to hepatic lipid metabolism, and growth performance. DNA methylation patterns are tissue specific, and thus it is not always negatively correlated with gene expression, challenging the traditional view that DNA methylation represses gene expression. Further work on the mechanistic connections between hepatic global and region DNA methylation with gene expression and functional proteins is required. Nutritional epigenomics, as an emerging and multi-disciplinary field of research, will help advance our understanding of the relationship between genes, molecules, and tissues in which methionine alteration influences DNA methylation and gene expression.
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[^1]: -: no change, ↑: increased, ↓: decreased.
